| Ident. | Authors (with country if any) | Title |
|---|
| 000031 |
C. A. Gautier [France] ; O. Corti [France] ; A. Brice [France] | Mitochondrial dysfunctions in Parkinson's disease |
| 000038 |
D. M. Johnstone [Australie] ; N. El Massri [Australie] ; C. Moro [France] ; S. Spana [Australie] ; X. S. Wang [Australie] ; N. Torres [France] ; C. Chabrol [France] ; X. De Jaeger [France] ; F. Reinhart [France] ; S. Purushothuman [Australie] ; A.-L. Benabid [France] ; J. Stone [Australie] ; J. Mitrofanis [Australie] | INDIRECT APPLICATION OF NEAR INFRARED LIGHT INDUCES NEUROPROTECTION IN A MOUSE MODEL OF PARKINSONISM - AN ABSCOPAL NEUROPROTECTIVE EFFECT |
| 000088 |
Jan T Nnesen [Suède, France] | Optogenetic cell control in experimental models of neurological disorders |
| 000107 |
M. Rolland [France] ; C. Carcenac [France] ; P. G. Overton [Royaume-Uni] ; M. Savasta [France] ; V. Coizet [France] | ENHANCED VISUAL RESPONSES IN THE SUPERIOR COLLICULUS AND SUBTHALAMIC NUCLEUS IN AN ANIMAL MODEL OF PARKINSON'S DISEASE |
| 000193 |
J. Bove [Espagne] ; C. Perier [Espagne] | NEUROTOXIN-BASED MODELS OF PARKINSON'S DISEASE |
| 000196 |
Nicolas Aznavour [France] ; Christophe Cendres-Bozzi [France] ; Laetitia Lemoine [France] ; Colette Buda [France] ; Jean-Pierre Sastre [France] ; Zoïa Mincheva [France] ; Luc Zimmer [France] ; Jian-Sheng Lin [France] | MPTP Animal Model of Parkinsonism: Dopamine Cell Death or Only Tyrosine Hydroxylase Impairment? - A Study Using PET Imaging, Autoradiography, and Immunohistochemistry in the Cat |
| 000232 |
Sophie Schumm [France] ; Claude Sebban [France] ; Charles Cohen-Salmon [France] ; Jacques Callebert [France] ; Jean-Marie Launay [France] ; Jean-Louis Golmard [France] ; Lydie Boussicault [France] ; Isabelle Petropoulos [France] ; Audrey Hild [France] ; Estelle Rousselet [France] ; Annick Prigent [France] ; Bertrand Friguet [France] ; Jean Mariani [France] ; Etienne C. Hirsch [France] | Aging of the dopaminergic system and motor behavior in mice intoxicated with the parkinsonian toxin 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine |
| 000235 |
P.-O. Fernagut [France] ; F. Tison [France] | ANIMAL MODELS OF MULTIPLE SYSTEM ATROPHY |
| 000236 |
H. Iderberg [Suède] ; V. Francardo [Suède] ; E. Y. Pioll [Royaume-Uni] | ANIMAL MODELS OF L-DOPA-INDUCED DYSKINESIA: AN UPDATE ON THE CURRENT OPTIONS |
| 000237 |
G. Madeo [Italie] ; G. Martella [Italie] ; T. Schirinzi [Italie] ; G. Ponterio [Italie] ; J. Shen [États-Unis] ; P. Bonsi [Italie] ; A. Pisani [Italie] | ABERRANT STRIATAL SYNAPTIC PLASTICITY IN MONOGENIC PARKINSONISMS |
| 000292 |
Varduhi H. Knaryan [États-Unis] ; Supriti Samantaray [États-Unis] ; Charlene Le Gal [France] ; Swapan K. Ray [États-Unis] ; Naren L. Banik [États-Unis] | Tracking extranigral degeneration in animal models of Parkinson's disease: quest for effective therapeutic strategies |
| 000300 |
Rui D. S. Prediger [Brésil] ; Aderbal S. Jr Aguiar [Brésil] ; Eduardo L. G. Moreira [Brésil] ; Filipe C. Matheus [Brésil] ; Adalberto A. Castro [Brésil] ; Roger Walz [Brésil] ; Andreza F. De Bem [Brésil] ; Alexandra Latini [Brésil] ; Carla I. Tasca [Brésil] ; Marcelo Farina [Brésil] ; Rita Raisman-Vozari [France] | The Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP): A New Rodent Model to Test Palliative and Neuroprotective Agents for Parkinson's disease |
| 000310 |
C. Baunez [France] ; J. Yelnik [France] ; L. Mallet [France] | SIX QUESTIONS ON THE SUBTHALAMIC NUCLEUS: LESSONS FROM ANIMAL MODELS AND FROM STIMULATED PATIENTS |
| 000323 |
Benjamin Dehay [France] ; Erwan Bezard [France] | New Animal Models of Parkinson's Disease |
| 000359 |
Masahiro Shin [France] ; Caroline Jan [France] ; Carine Jacquard [France] ; Bechir Jarraya [France] ; Jacques Callebert [France] ; Jean-Marie Launay [France] ; Philippe Hantraye [France] ; Philippe Remy [France] ; Stephane Palfi [France] ; Emmanuel Brouillet [France] | Chronic systemic treatment with a high-dose proteasome inhibitor in mice produces akinesia unrelated to nigrostriatal degeneration |
| 000369 |
Erwan Bezard [France] ; Serge Przedborski [États-Unis] | A Tale on Animal Models of Parkinson's Disease |
| 000390 |
Léon Tremblay [France] | Où en sommes-nous sur la physiopathologie de la maladie de Parkinson ? |
| 000488 |
Stephane Besnard [France] ; Michael Decressac [France] ; Pierre Denise [France] | In-vivo deep brain recordings of intranigral grafted cells in a mouse model of Parkinson's disease |
| 000507 |
A. Faure [France] ; P. Leblanc-Veyrac [France] ; N. El Massioui [France] | DOPAMINE AGONISTS INCREASE PERSEVERATIVE INSTRUMENTAL RESPONSES BUT DO NOT RESTORE HABIT FORMATION IN A RAT MODEL OF PARKINSONISM |
| 000608 |
Elvira De Leonibus [Italie] ; Francesca Manago [Italie] ; Francesco Giordani [Italie] ; Francesco Petrosino [Italie] ; Sebastien Lopez [France] ; Alberto Oliverio [Italie] ; Marianne Amalric [France] ; Andrea Mele [Italie] | Metabotropic Glutamate Receptors 5 Blockade Reverses Spatial Memory Deficits in a Mouse Model of Parkinson's Disease |
| 000612 |
Vincent Henry [France] ; Vincent Paille [France] ; Faustine Lelan [France] ; Philippe Brachet [France] ; Philippe Damier [France] | Kinetics of Microglial Activation and Degeneration of Dopamine-Containing Neurons in a Rat Model of Parkinson Disease Induced by 6-Hydroxydopamine |
| 000645 |
Stefan Schuster [Allemagne] ; Evelyne Doudnikoff [France] ; Daniella Rylander [Suède] ; Amandine Berthet [France] ; Incarnation Aubert [France] ; Carina Ittrich [Allemagne] ; Bertrand Bloch [France] ; M. Angela Cenci [Suède] ; D. James Surmeier [États-Unis] ; Bastian Hengerer [Allemagne] ; Erwan Bezard [France] | Antagonizing L-type Ca2+ Channel Reduces Development of Abnormal Involuntary Movement in the Rat Model of L-3,4-Dihydroxyphenylalanine-Induced Dyskinesia |
| 000692 |
Erwan Bezard [France] | L-dopa, un jour et pour toujours |
| 000697 |
Jacques Epelbaum [France] | Foxa2, une nouvelle piste neuro-développementale pour le Parkinson |
| 000707 |
Laura Flinn [Royaume-Uni] ; Sandrine Bretaud [France] ; Christine Lo [Royaume-Uni] ; Phillip W. Ingham [Royaume-Uni] ; Oliver Bandmann [Royaume-Uni] | Zebrafish as a new animal model for movement disorders |
| 000718 |
Anthony P. Nicholas [États-Unis] ; Farah D. Lubin [États-Unis] ; Penelope J. Hallett [États-Unis] ; Padmapriya Vattem [États-Unis] ; Paula Ravenscroft [Royaume-Uni] ; Erwan Bezard [France] ; SHAOBO ZHOU [Royaume-Uni] ; Susan H. Fox [Canada] ; Jonathan M. Brotchie [Canada] ; J. David Sweatt [États-Unis] ; David G. Standaert [États-Unis] | Striatal histone modifications in models of levodopa-induced dyskinesia |
| 000728 |
Daniel Hamack [Allemagne] ; Wassilios Meissner [France] ; Julia A. Jira [Allemagne] ; Christine Winter [Allemagne] ; Rudolf Morgenstern [Allemagne] ; Andreas Kupsch [Allemagne] | Placebo-controlled chronic high-frequency stimulation of the subthalamic nucleus preserves dopaminergic nigral neurons in a rat model of progressive Parkinsonism |
| 000730 |
Gaëlle Bouchez [France] ; Luc Sensebe [France] ; Patrick Vourc'H [France] ; Lucette Garreau [France] ; Sylvie Bodard [France] ; Angélique Rico [France] ; Denis Guilloteau [France] ; Pierre Charbord [France] ; Jean-Claude Besnard [France] ; Sylvie Chalon [France] | Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease |
| 000737 |
Dieter Scheller [Allemagne] ; Christine Stichel-Gunkel [Allemagne] ; Hermann Lübbert [Allemagne] ; Gregory Porras [France] ; Paula Ravenscroft [Royaume-Uni] ; Michael Hill [Royaume-Uni] ; Erwan Bezard [France, Royaume-Uni] | Neuroprotective effects of rotigotine in the acute MPTP-lesioned mouse model of Parkinson's disease |
| 000742 |
Daniel Alvarez-Fischer [France] ; Serge Guerreiro [France] ; Stephane Hunot [France] ; Francoise Saurini [France] ; Marc Marien [France] ; Pierre Sokoloff [France] ; Etienne C. Hirsch [France] ; Andreas Hartmann [France] ; Patrick P. Michel [France] | Modelling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecid |
| 000745 |
Carine Chassain [France] ; Guy Bielicki [France] ; Elodie Durand [France] ; Stéphane Lolignier [France] ; Fatma Essafi [Tunisie] ; Amidou Traore [France] ; Franck Durif [France] | Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse |
| 000781 |
Daniel Alvarez-Fischer [Allemagne] ; Carmen Henze [Allemagne] ; Corinna Strenzke [Allemagne] ; Jan Westrich [Allemagne] ; Boris Ferger [Allemagne] ; Günter U. Höglinger [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Andreas Hartmann [Allemagne, France] | Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and α-synuclein-deleted mice |
| 000820 |
Dominique Langui [France] ; Francois Lachapelle [France] ; Charles Duyckaerts [France] | Modèles animaux des maladies neurodégénératives |
| 000850 |
Elvira De Leonibus [Italie] ; Tiziana Pascucci [Italie] ; Sebastien Lopez [France] ; Alberto Oliverio [Italie] ; Marianne Amalric [France] ; Andrea Mele [Italie] | Spatial deficits in a mouse model of Parkinson disease |
| 000851 |
Elvira De Leonibus [Italie] ; Tiziana Pascucci [Italie] ; Sebastien Lopez [France] ; Alberto Oliverio [Italie] ; Marianne Amalric [France] ; Andrea Mele [Italie] | Spatial deficits in a mouse model of Parkinson disease |
| 000860 |
Vincent Paille [France] ; Vincent Henry [France] ; Laurent Lescaudron [France] ; Philippe Brachet [France] ; Philippe Damier [France] | Rat model of Parkinson's disease with bilateral motor abnormalities, reversible with levodopa, and dyskinesias |
| 000864 |
SHUHONG GUO [République populaire de Chine] ; JINGQI YAN [République populaire de Chine, France] ; TANGBIN YANG [République populaire de Chine] ; XIANQIANG YANG [République populaire de Chine] ; Erwan Bezard [République populaire de Chine] ; BAOLU ZHAO [République populaire de Chine] | Protective Effects of Green Tea Polyphenols in the 6-OHDA Rat Model of Parkinson's Disease Through Inhibition of ROS-NO Pathway |
| 000866 |
Constance Hammond [France] ; Hagai Bergman [Israël] ; Peter Brown [Royaume-Uni] | Pathological synchronization in Parkinson's disease : networks, models and treatments |
| 000867 |
Duong P. Huynh [États-Unis] ; Dung T. Nguyen [États-Unis] ; Johannes B. Pulst-Korenberg [États-Unis] ; Alexis Brice [France] ; Stefan-M. Pulst [États-Unis] | Parkin is an E3 ubiquitin-ligase for normal and mutant ataxin-2 and prevents ataxin-2-induced cell death |
| 000880 |
Alexandre Kreisler [France] ; Patrick Gele [France] ; Jean-Francois Wiart [France] ; Michel Lhermitte [France] ; Alain Destke [France] ; Régis Bordet [France] | Lipid-lowering drugs in the MPTP mouse model of Parkinson's disease : Fenofibrate has a neuroprotective effect, whereas bezafibrate and HMG-CoA reductase inhibitors do not |
| 000883 |
Emmanuelle Lagrue [France] ; Sylvie Chalon [France] ; Sylvie Bodard [France] ; Elie Saliba [France] ; Pierre Gressens [France] ; Pierre Castelnau [France] | Lamotrigine is neuroprotective in the energy deficiency model of MPTP intoxicated mice |
| 000896 |
S. Breit [France, Allemagne] ; R. Bouali-Benazzouz [France] ; R. C. Popa [Allemagne] ; T. Gasser [Allemagne] ; A. L. Benabid [France] ; A. Benazzouz [France] | Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat |
| 000A58 |
I. Ghorayeb [France] ; E. Bezard [France] ; P. O. Fernagut [France] ; B. Bioulac [France] ; F. Tison [France] | Modèles animaux des syndromes parkinsoniens |
| 000B01 |
Carmen Henze [France] ; Andreas Hartmann [France] ; Thomas Lescot [France] ; Etienne C. Hirsch [France] ; Patrick P. Michel [France] | Proliferation of microglial cells induced by 1-methyl-4-phenylpyridinium in mesencephalic cultures results from an astrocyte-dependent mechanism : role of granulocyte macrophage colony-stimulating factor |
| 000B04 |
R. Robichon [France] ; A. Jaafar [France] ; M. Terqui [France] ; P. Brachet [France] ; M. Peschanski [France] | Pig xenografts to the immunocompetent rat brain : Survival rates using distinct neurotoxic lesions in the nigrostriatal pathway and two rat strains |
| 000B24 |
Nathalie Turle-Lorenzo [France] ; Nathalie Breysse [France] ; Christelle Baunez [France] ; Marianne Amalric [France] | Functional interaction between mGlu 5 and NMDA receptors in a rat model of Parkinson's disease |
| 000B31 |
Thomas Debeir [France] ; Laure Ginestet [France] ; Chantal Francois [France] ; Stéphanie Laurens [France] ; Jean-Claude Martel [France] ; Philippe Chopin [France] ; Marc Marien [France] ; Francis Colpaert [France] ; Rita Raisman-Vozari [France] | Effect of intrastriatal 6-OHDA lesion on dopaminergic innervation of the rat cortex and globus pallidus |
| 000B79 |
Philippe Remy [France] ; Stéphane Palfi [France] ; Philippe Hantraye [France] | Le suivi lésionnel et thérapeutique des maladies neurodégénératives par l'imagerie fonctionnelle |
| 000B83 |
E. Villard [France] | Génétique |
| 000C14 |
Paula Ravenscroft [Royaume-Uni] ; Sylvie Chalon [France] ; Jonathan M. Brotchie [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] | Ropinirole versus L-DOPA effects on striatal opioid peptide precursors in a rodent model of Parkinson's disease: implications for dyskinesia |
| 000C15 |
Vincent Paille [France] ; Philippe Brachet [France] ; Philippe Damier [France] | Role of nigral lesion in the genesis of dyskinesias in a rat model of Parkinson's disease |
| 000C29 |
P. O. Fernagut [France] ; E. Diguet [France] ; B. Bioulac [France] ; F. Tison [France] | MPTP potentiates 3-nitropropionic acid-induced striatal damage in mice: eeference to striatonigral degeneration |
| 000C30 |
Christophe Jollivet [France] ; Anne Aubert-Pouessel [France] ; Anne Clavreul [France] ; Marie-Claire Venier-Julienne [France] ; Claudia N. Montero-Menei [France] ; Jean-Pierre Benoit [France] ; Philippe Menei [France] | Long-term effect of intra-striatal glial cell line-derived neurotrophic factor-releasing microspheres in a partial rat model of Parkinson's disease |
| 000C56 |
N. A. Do Thi [France] ; P. Saillour [France] ; L. Ferrero [France] ; I. F. Dedieu [France] ; J. Mallet [France] ; T. Paunio [France, Finlande] | Delivery of GDNF by an E1,E3/E4 deleted adenoviral vector and driven by a GFAP promoter prevents dopaminergic neuron degeneration in a rat model of Parkinson's disease |
| 000C60 |
N. Hamaue [Japon] ; M. Minami [Japon] ; M. Terado [Japon] ; M. Hirafuji [Japon] ; T. Endo [Japon] ; M. Machida [Japon] ; T. Hiroshige [Japon] ; A. Ogata [Japon] ; K. Tashiro [Japon] ; H. Saito [Japon] ; S. H. Parvez [France] | Comparative study of the effects of isatin, an endogenous MAO-inhibitor, and selegiline on bradykinesia and dopamine levels in a rat model of Parkinson's disease induced by the Japanese encephalitis virus |
| 000C68 |
Elsa Y. Pioli [France] ; Sandra Dovero [France] ; Bernard H. Bioulac [France] ; Christian E. Gross [France] ; Erwan Bezard [France] | Asymmetrically lesioned mesencephalon in healthy rodents: call for caution |
| 000D35 |
Guillaume Hebert [France] ; Josette Arsaut [France] ; Robert Dantzer [France] ; Jacques Demotes-Mainard [France] | Time-course of the expression of inflammatory cytokines and matrix metalloproteinases in the striatum and mesencephalon of mice injected with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a dopaminergic neurotoxin |
| 000D54 |
Michael P. Hill [Royaume-Uni] ; Erwan Bezard [France] ; Steven G. Mcguire [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Canada] ; Ann Michel [Belgique] ; Renee Grimee [Belgique] ; Henrik Klitgaard [Belgique] | Novel antiepileptic drug levetiracetam decreases dyskinesia elicited by L-dopa and ropinirole in the MPTP-lesioned marmoset |
| 000D60 |
Jose-Luis Gonzalez De Aguilar [France] ; Frédérique Rene [France] ; Luc Dupuis [France] ; Jean-Philippe Loeffler [France] | Neuroendocrinology of neurodegenerative diseases: Insights from transgenic mouse models |
| 000D68 |
Jean-René Martin [France] | Locomotor activity: a complex behavioural trait to unravel |
| 000D92 |
L. Escola [France] ; Th. Michelet [France] ; F. Macia [France] ; D. Guehl [France] ; B. Bioulac [France] ; P. Burbaud [France] | Disruption of information processing in the supplementary motor area of the MPTP-treated monkey: A clue to the pathophysiology of akinesia? |
| 000E93 |
Stéphanie Barc [France] ; Guylène Page [France] ; Laurence Barrier [France] ; Lucette Garreau [France] ; Denis Guilloteau [France] ; Bernard Fauconneau [France] ; Sylvie Chalon [France] | Relevance of different striatal markers in assessment of the MPP+-induced dopaminergic nigrostriatal injury in rat |
| 000F24 |
Samuel G. Speciale [États-Unis] | MPTP: Insights into parkinsonian neurodegeneration |
| 000F26 |
Marie-Paule Muriel [France] ; Gaël Orieux [France] ; Etienne C. Hirsch [France] | Levodopa but not ropinirole induces an internalization of D1 dopamine receptors in Parkinsonian rats |
| 000F45 |
A. D. Smith [États-Unis] ; M. Amalric [France] ; G. F. Koob [États-Unis] ; M. J. Zigmond [États-Unis] | Effect of bilateral 6-hydroxydopamine lesions of the medial forebrain bundle on reaction time |
| 000F46 |
I. Ghorayeb [France] ; P. O. Fernagut [France] ; N. Stefanova [Autriche] ; G. K. Wenning [Autriche] ; B. Bioulac [France] ; F. Tison [France] | Dystonia is predictive of subsequent altered dopaminergic responsiveness in a chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine + 3-nitropropionic acid model of striatonigral degeneration in monkeys |
| 000F53 |
Ludovic Escola [France] ; Thomas Michelet [France] ; Gaelle Douillard [France] ; Dominique Guehl [France] ; Bernard Bioulac [France] ; Pierre Burbaud [France] | Disruption of the proprioceptive mapping in the medial wall of parkinsonian monkeys |
| 001024 |
Zhong-Ge Ni [France] ; Rabia Bouali-Benazzouz [France] ; Dong-Ming Gao [République populaire de Chine] ; Alim-Louis Benabid [France] ; Abdelhamid Benazzouz [France] | Time-course of changes in firing rates and firing patterns of subthalamic nucleus neuronal activity after 6-OHDA-induced dopamine depletion in rats |
| 001043 |
Karine Parain [France] ; Véronique Marchand [France] ; Bernard Dumery [France] ; Etienne Hirsch [France] | Nicotine, but not cotinine, partially protects dopaminergic neurons against MPTP-induced degeneration in mice |
| 001080 |
Thomas Boraud [France] ; Erwan Bezard [France] ; Bernard Bioulac [France] ; Christian E. Gross [France] | Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey |
| 001087 |
Hélène Turmel [France] ; Andreas Hartmann [France] ; Karine Parain [France] ; Aicha Doubou [France] ; Anu Srinivasan [États-Unis] ; Yves Agid [France] ; Etienne C. Hirsch [France] | Caspase-3 activation in 1 -methyl-4-phenyl- 1, 2,3,6-tetrahydropyridine (MPTP)-treated mice |
| 001092 |
C. Chassain [France] ; A. Eschalier [France] ; F. Durif [France] | Assessment of motor behavior using a video system and a clinical rating scale in parkinsonian monkeys lesioned by MPTP |
| 001094 |
Stéphanie Barc [France] ; Guylène Page [France] ; Bernard Fauconneau [France] ; Laurence Barrier [France] ; Francois Huguet [France] | A new in vitro approach for investigating the MPTP effect on DA uptake |
| 001098 |
| Pharmacologie des récepteurs métabotropiques du glutamate Implication dans la douleur |
| 001170 |
Z. G. Ni [France] ; D. M. Gao [République populaire de Chine] ; A. L. Benabid [France] ; A. Benazzouz [France] | Unilateral lesion of the nigrostriatal pathway induces a transient decrease of firing rate with no change in the firing pattern of neurons of the parafascicular nucleus in the rat |
| 001171 |
E. Aliaga [Chili] ; C. Carcamo [Chili] ; J. Abarca [Chili] ; L. Tapia-Arancibia [France] ; G. Bustos [Chili] | Transient increase of brain derived neurotrophic factor mRNA expression in substantia nigra reticulata after partial lesion of the nigrostriatal dopaminergic pathway |
| 001177 |
M. G. Murer [France, Argentine] ; G. Dziewczapolski [Argentine] ; P. Salin [France] ; M. Vila [France] ; K. Y. Tseng [Argentine] ; M. Ruberg [France] ; M. Rubinstein [Argentine] ; M. A. Kelly [États-Unis] ; D. K. Grandy [États-Unis] ; M. J. Low [États-Unis] ; E. Hirsch [France] ; R. Raisman-Vozari [France] ; O. Gershanik [Argentine] | The indirect basal ganglia pathway in dopamine D2 receptor-deficient mice |
| 001188 |
M. Grandbois [Canada] ; M. Morissette [Canada] ; S. Callier [Canada, France] ; T. Di Paolo [Canada] | Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice |
| 001198 |
N. W. Kowall [États-Unis] ; P. Hantraye [France] ; E. Brouillet [France] ; M. F. Beal [États-Unis] ; A. C. Mckee [États-Unis] ; R. J. Ferrante [États-Unis] | MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons |
| 001204 |
C. Perier [France] ; Yves Agid [France] ; E. C. Hirsch [France] ; J. Feger [France] | Ipsilateral and contralateral subthalamic activity after unilateral dopaminergic lesion |
| 001221 |
T. Boraud [France] ; E. Bezard [France] ; J. M. Stutzmann [France] ; B. Bioulac [France] ; C. E. Gross [France] | Effects of riluzole on the electrophysiological activity of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey |
| 001232 |
C. Scherfler [Autriche] ; Z. Puschban [Autriche] ; I. Ghorayeb [France] ; G. P. Goebel [Autriche] ; F. Tison [France] ; K. Jellinger [Autriche] ; Werner Poewe [Autriche] ; G. K. Wenning [Autriche] | Complex motor disturbances in a sequential double lesion rat model of striatonigral degeneration (multiple system atrophy) |
| 001233 |
C. Imbert [France] ; E. Bezard [France] ; S. Guitraud [France] ; T. Boraud [France] ; C. E. Gross [France] | Comparison of eight clinical rating scales used for the assessment of MPTP-induced parkinsonism in the Macaque monkey |
| 001235 |
W.-J. Gu [France] ; N. Abbas [France] ; M. Z. Lagunes [France] ; A. Parent [France] ; L. Pradier [France] ; G. A. Bohme [France] ; Yves Agid [France] ; E. C. Hirsch [France] ; R. Raisman-Vozari [France] ; A. Brice [France] | Cloning of rat parkin cDNA and distribution of parkin in rat brain |
| 001258 |
| CONTRIBUTION A L'ETUDE DES VARIATIONS PHYSIOLOGIQUES ET PATHOLOGIQUES DES PRESSIONS URETRALES CHEZ L'ANIMAL ET CHEZ L'HOMME |
| 001292 |
V. Ben [France] ; O. Blin [France] ; B. Bruguerolle [France] | Time-dependent striatal dopamine depletion after injection of 6-hydroxydopamine in the rat. Comparison of single bilateral and double bilateral lesions |
| 001315 |
M. Merad-Saïdoune [France] ; E. Boitier [France] ; A. Nicole [France] ; C. Marsac [France] ; J. C. Martinou [Suisse] ; B. Sola [France] ; P.-M. Sinet [France] ; I. Ceballos-Picot [France] | Overproduction of Cu/Zn-superoxide dismutase or Bcl-2 prevents the brain mitochondrial respiratory dysfunction induced by glutathione depletion |
| 001328 |
C. Fillebeen [France] ; V. Mitchell [France] ; D. Dexter [Royaume-Uni] ; M. Benaissa [France] ; J.-C. Beauvillain [France] ; G. Spik [France] ; A. Pierce [France] | Lactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment |
| 001332 |
M. G. Murer [Argentine] ; J. Ferrario [Argentine] ; M. Delfino [Argentine] ; G. Dziewczapolski [Argentine] ; O. S. Gershanik [Argentine] ; R. Raisman-Vozari [France] | Increased [125I]sulpiride binding in the subthalamic nucleus of rats with nigrostriatal lesions |
| 001368 |
E. Bezard [France] ; C. E. Gross [France] ; M.-C. Fournier [France] ; S. Dovero [France] ; B. Bloch [France] ; M. Jaber [France] | Absence of MPTP-lnduced neuronal death in mice lacking the dopamine transporter |
| 001372 |
J. A. Aguirre [Espagne] ; A. Cintra [Suède] ; J. Hillion [Suède] ; J. A. Narvaez [Espagne] ; A. Jansson [Suède] ; T. Antonelli [Italie] ; L. Ferraro [Italie] ; F. A. Rambert [France] ; K. Fuxe [Suède] | A stereological study on the neuroprotective actions of acute Modafinil treatment on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigral lesions of the male black mouse |
| 001425 |
H. Bergman [Israël] ; A. Raz [Israël] ; A. Feingold [Israël] ; A. Nini [Israël] ; I. Nelken [Israël] ; D. Hansel [France] ; H. Ben-Pazi [Israël] ; A. Reches [Israël] | Physiology of MPTP tremor |
| 001435 |
P. Hantraye [France] | Modeling dopamine system dysfunction in experimental animals |
| 001463 |
M. G. Murer [France] ; G. Dziewczapolski [Argentine] ; L. B. Menalled [Argentine] ; M. C. Garcia [Argentine] ; Yves Agid [France] ; O. Gershanik [Argentine] ; R. Raisman-Vozari [France] | Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions |
| 001467 |
N. Aubin [France] ; O. Curet [France] ; A. Deffois [France] ; C. Carter [France] | Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice |
| 001478 |
| Effet de la mutation weaver sur la dégénérescence des neurones dopaminergiques du mésencéphale ventral : analyse de l'expression du transporteur membranaire de la dopamine et d'un canal potassique couplé à une protéine G |
| 001481 |
| CONTROLE DOPAMINERGIQUE DU NOYAU SYBTHALAMIQUE CHEZ LE RAT NORMAL ET CHEZ LE RAT MODELE DE LA MALADIE DE PARKINSON (RATS 6-OHDA) |
| 001569 |
E. Bezard [France] ; S. Dovero [France] ; B. Bioulac [France] ; C. E. Gross [France] | Kinetics of nigral degeneration in a chronic model of MPTP-treated mice |
| 001595 |
C. Adelbrecht [France] ; M. G. Murer [France] ; I. Lauritzen [France] ; F. Lesage [France] ; M. Ladzunski [France] ; Yves Agid [France] ; R. Raisman-Vozari [France] | An immunocytochemical study of a G-protein-gated inward rectifier K+ channel (GIRK2) in the weaver mouse mesencephalon |
| 001601 |
E. Bezard [France] ; C. Imbert [France] ; X. Deloire [France] ; B. Bioulac [France] ; C. E. Gross [France] | A chronic MPTP model reproducing the slow evolution of Parkinson's disease: evolution of motor symptoms in the monkey |
| 001641 |
P. Barneoud [France] ; M. Mazadier [France] ; J.-M. Miquet [France] ; S. Parmentier [France] ; P. Dubedat [France] ; A. Doble [France] ; A. Boireau [France] | Neuroprotective effects of riluzole on a model of Parkinson's disease in the rat |
| 001647 |
O.-K. Hassani [France] ; M. Mouroux [France] ; J. Feger [France] | Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus |
| 001678 |
| Utilisation et amélioration de l'adénovirus en tant que vecteur viral pour le tranfert de gènes |
| 001713 |
JA-HYUN BAIK [France] ; R. Picetti [France] ; A. Saiardi [France] ; G. Thiriet [France] ; A. Dierich [France] ; A. Depaulis [France] ; M. Le Meur [France] ; E. Borrelli [France] | Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors |
| 001728 |
P. Barneoud [France] ; S. Parmentier ; M. Mazadier ; J. M. Miquet ; A. Boireau ; P. Dubedat ; J.-C. Blanchard | Effects of complete and partial lesions of the dopaminergic mesotelencephalic system on skilled forelimb use in the rat |
| 001747 |
| Réalisation et caractérisation chez le babouin d'un modèle expérimental chronique de la maladie de Parkinson |
| 001807 |
P. Horellou [France] ; E. Vigne [France] ; M.-N. Castel [France] ; P. Barneoud [France] ; P. Colin [France] ; M. Perricaudet [France] ; P. Delaere [France] ; J. Mallet [France] | Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease |
| 001879 |
M. T. Herrero [France] ; I. Perez-Otano ; C. Oset ; A. Kastner [France] ; E. C. Hirsch [France] ; Yves Agid [France] ; M. R. Luquin ; J. A. Obeso ; J. Del Rio | GM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys |
| 001888 |
M. T. Herrero [France] ; E. C. Hirsch [France] ; A. Kastner [France] ; M. Ruberg [France] ; M. R. Luquin ; J. Laguna ; F. Javoy-Agid [France] ; J. A. Obeso ; Yves Agid [France] | Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP ? |
| 001890 |
M. T. Herrero [France] ; E. C. Hirsch [France] ; F. Javoy-Agid [France] ; J. A. Obeso ; Yves Agid [France] | Differential vulnerability to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of dopaminergic and cholinergic neurons in the monkey mesopontine tegmentum |
| 001953 |
A. Benazzouz [France] ; C. Gross ; J. Dupont [France] ; B. Bioulac | MPTP induced hemiparkinsonism in monkeys : behavioral, mechanographic, electromyographic and immunohistochemical studies |
| 001969 |
| Expression du gène de la tyrosine hydroxylase dans divers systèmes hétérologues; greffes de cellules modifiées génétiquement libérant la L-DOPA ou la dopamine dans un modèle animal de la maladie de Parkinson |
| 001979 |
S. Ammar [France] ; P. Martin | Modélisations des effets des agonistes dopaminergiques en psychopharmacologie : vers une homothétie clinique et expérimentale |
| 001A82 |
B. Cura ; M. Valli | Intérêts du modèle au 1 méthyl 4 phényl 1, 2, 3, 6 tétrahydropyridine (MPTP) dans la physiopathologie de la maladie de Parkinson |
| 001B83 |
P. Hantraye ; C. Loc'H ; U. Tacke ; D. Riche ; O. Stulzaft ; D. Doudet ; B. Guibert ; R. Naquet ; B. Maziere ; M. Maziere | "In vivö visualization by positron emission tomography of the progressive striatal dopamine receptor damage occurring in MPTP-intoxicated non-human primates |
| 001B93 |
D. Doudet ; C. Gross ; P. Lebrun-Grandie ; B. Bioulac | MPTP primate model of Parkinson's disease: a mechanographic ansd electromyographic study |
